The Cooper Companies Inc. Fourth Quarter Earnings Sneak Peek

The Cooper Companies, Inc. (NYSE:COO) will unveil its latest earnings on Thursday, December 8, 2011. Cooper Companies develops, manufactures, and markets healthcare products, primarily medical devices through its two business units: CooperVision and CooperSurgical.

The Cooper Companies, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of $1.21 per share, a rise of 16.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.22. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. For the year, analysts are projecting profit of $4.23 per share, a rise of 39.1% from last year.

Past Earnings Performance: Last quarter, the company beat estimates by 7 cents, coming in at net income of $1.15 a share versus the estimate of profit of $1.08 a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Wall St. Revenue Expectations: Analysts are projecting a rise of 13.9% in revenue from the year-earlier quarter to $356.9 million.

Analyst Ratings: Analysts are bullish on this stock with five analysts rating it as a buy, none rating it as a sell and three rating it as a hold.

A Look Back: In the third quarter, profit fell 4% to $38.1 million (78 cents a share) from $39.7 million (86 cents a share) the year earlier, but exceeded analyst expectations. Revenue rose 18.9% to $351.4 million from $295.6 million.

Key Stats:

The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 13.6%, with the biggest boost coming in the most recent quarter when revenue rose 18.9% from the year earlier quarter.

The decrease in profit in the third quarter broke a streak of three consecutive quarters of year-over-year profit increases. Net income rose more than sevenfold in the second quarter, more than twofold in the first quarter and 60% in the fourth quarter of the last fiscal year.

Competitors to Watch: STAAR Surgical Company (NASDAQ:STAA), Teleflex Incorporated (NYSE:TFX), Utah Medical Products, Inc. (NASDAQ:UTMD), Atrion Corporation (NASDAQ:ATRI), Covidien plc (NYSE:COV), Shamir Optical Industry Ltd. (NASDAQ:SHMR), Novartis AG (NYSE:NVS), C.R. Bard, Inc. (NYSE:BCR), Johnson & Johnson (NYSE:JNJ), and Boston Scientific Corp. (NYSE:BSX).

Stock Price Performance: During October 6, 2011 to December 2, 2011, the stock price had fallen $18.51 (-23.6%) from $78.48 to $59.97. The stock price saw one of its best stretches over the last year between January 28, 2011 and February 14, 2011 when shares rose for 12-straight days, rising 8.9% (+$5.07) over that span. It saw one of its worst periods between July 19, 2011 and July 28, 2011 when shares fell for eight-straight days, falling 5.6% (-$4.57) over that span. Shares are up $3.68 (+6.5%) year to date.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.